Stock Market News2 weeks GSK to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion Investing.com
GSK to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion.
XGSK to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion.
X